Breast Cancer Screening and Solid Organ Transplantation

Area of Science:

• Transplantation Medicine
• Oncology
• Public Health

Background:

• Solid organ transplantation in the U.S. has increased significantly over the last decade.
• Thorough pre-transplant evaluations are essential for appropriate organ allocation.
• Active malignancy is a contraindication for most solid organ transplantations.

Purpose of the Study:

• To summarize the current practices of breast cancer screening for solid organ transplant candidates and donors in the United States.
• To highlight the importance of integrating cancer screening into the pre-transplant assessment process.

Main Methods:

• Review of current literature and guidelines on solid organ transplant-related cancer screening.
• Analysis of existing pre-transplant protocols in the United States.

Main Results:

• Breast cancer screening is a critical component of the pre-transplant evaluation.
• Guidelines and practices for screening may vary, necessitating standardization.

Conclusions:

• Comprehensive cancer screening, including for breast cancer, is vital for potential solid organ transplant recipients and donors.
• Standardized screening protocols can improve patient outcomes and optimize organ allocation.